Literature DB >> 2096691

Blood flow, oxygen consumption and tissue oxygenation of human tumors.

P Vaupel1, F Kallinowski, P Okunieff.   

Abstract

The objective of this article was to summarize current knowledge of blood flow and oxygen supply to human tumors, parameters which go hand in hand, and in turn critically determine the cellular metabolic microenvironment of human malignancies. A compilation of available data on blood flow, oxygen supply, and tissue oxygen distribution in human tumors is presented. Though data on human tumors in situ are scarce and there may be significant errors associated with the techniques used for measurements, experimental evidence is provided for the existence of a compromised and anisotropic blood supply to many tumors. Comparable to rodent tumors, O2-depleted areas develop in human malignancies which coincide with nutrient and energy deprivation, and with a hostile metabolic microenvironment. Significant variations in these relevant parameters have to be expected between different locations within the same tumor, at the same location at different times, and between individual tumors of the same grading and staging.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2096691     DOI: 10.1007/978-1-4684-8181-5_103

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  13 in total

Review 1.  Causes and effects of heterogeneous perfusion in tumors.

Authors:  R J Gillies; P A Schornack; T W Secomb; N Raghunand
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer: Proof of Concept for FMISO-PET.

Authors:  Nils D Arvold; Pedram Heidari; Anchisa Kunawudhi; Lecia V Sequist; Umar Mahmood
Journal:  Technol Cancer Res Treat       Date:  2015-03-10

Review 3.  Hyperbaric oxygen therapy for malignancy: a review.

Authors:  Jurstine Daruwalla; Chris Christophi
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

Review 4.  EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?

Authors:  Mauro Di Vito Nolfi; Davide Vecchiotti; Irene Flati; Daniela Verzella; Monica Di Padova; Edoardo Alesse; Daria Capece; Francesca Zazzeroni
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

5.  Platelet granule secretion continuously prevents intratumor hemorrhage.

Authors:  Benoit Ho-Tin-Noé; Tobias Goerge; Stephen M Cifuni; Daniel Duerschmied; Denisa D Wagner
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

6.  Advantages and disadvantages of 3D ultrasound of thyroid nodules including thin slice volume rendering.

Authors:  Rafal Zenon Slapa; Wieslaw Stanislaw Jakubowski; Jadwiga Slowinska-Srzednicka; Kazimierz Tomasz Szopinski
Journal:  Thyroid Res       Date:  2011-01-07

7.  Connexin-43 channels are a pathway for discharging lactate from glycolytic pancreatic ductal adenocarcinoma cells.

Authors:  T H Dovmark; M Saccomano; A Hulikova; F Alves; P Swietach
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

Review 8.  Activation of nuclear factor-κB in the angiogenesis of glioma: Insights into the associated molecular mechanisms and targeted therapies.

Authors:  Jiajie Tu; Yilong Fang; Dafei Han; Xuewen Tan; Haifeng Jiang; Xun Gong; Xinming Wang; Wenming Hong; Wei Wei
Journal:  Cell Prolif       Date:  2020-12-10       Impact factor: 6.831

Review 9.  Breast tumour angiogenesis.

Authors:  Stephen B Fox; Daniele G Generali; Adrian L Harris
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

10.  Hypoxia and IF₁ Expression Promote ROS Decrease in Cancer Cells.

Authors:  Gianluca Sgarbi; Giulia Gorini; Francesca Liuzzi; Giancarlo Solaini; Alessandra Baracca
Journal:  Cells       Date:  2018-06-21       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.